Caliber Imaging & Diagnostics, Inc. (LCDX) Research
Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.
Market snapshot
- Symbol
- LCDX
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $5.1K
- P/E ratio
- -0.00x
- 52-week range
- 0.0001-0.0008
- Sector
- Healthcare
- Industry
- Medical - Devices
Peer companies
Recent insider activity
- CHRISTOPHER RICHARD — trade (0 shares) on 2014-03-18
- SHEA WILLIAM J — A-Award (500000 shares) on 2013-09-13
- SHEA WILLIAM J — P-Purchase (214286 shares) on 2012-12-18
- SHEA WILLIAM J — G-Gift (300000 shares) on 2012-12-19
- SHEA WILLIAM J — G-Gift (300000 shares) on 2012-12-19
Open Caliber Imaging & Diagnostics, Inc. (LCDX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.